![Lyn M. Dyster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lyn M. Dyster
Private Equity Investor bei Volante Capital LLC
Profil
Dr. Lyn M.
Dyster is a Managing Director at Volante Capital LLC.
Dr. Dyster was previously employed as a Senior Vice President-Operations by Athenex, Inc. and a Principal by Cellular Products, Inc.
She received her undergraduate degree from Washington & Jefferson College, a doctorate degree from State University of New York at Buffalo and a doctorate degree from State University of New York at Buffalo.
Aktive Positionen von Lyn M. Dyster
Unternehmen | Position | Beginn |
---|---|---|
Volante Capital LLC
![]() Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Lyn M. Dyster
Unternehmen | Position | Ende |
---|---|---|
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Corporate Officer/Principal | - |
ATHENEXPAR | Gründer | - |
Ausbildung von Lyn M. Dyster
State University of New York at Buffalo | Doctorate Degree |
Washington & Jefferson College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Cellular Products, Inc.
![]() Cellular Products, Inc. Medical SpecialtiesHealth Technology Cellular Products, Inc. manufactures biotechnology materials for diagnostic test kits. The private company is based in Buffalo, NY. The company was founded by Jeffrey N. Meshulam. | Health Technology |
Volante Capital LLC
![]() Volante Capital LLC Investment ManagersFinance Volante Capital LLC (Volante Capital) is a private equity firm founded in 2006 by Victor Lazzaro and Terry W. White. The firm is headquartered in Denver, Colorado. | Finance |